A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
Kerry-Ann L Dillon 1, 2 1Department of Microbiology, Immunology and Pharmacology, St. George’s University School of Medicine, True Blue, Grenada; 2Department of Dermatology, School of Health, Sport & Professional Practice, Faculty of Life Sciences and Education, University of South Wal...
Saved in:
Main Author: | Dillon KAL (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
by: Xingqi ZHANG
Published: (2022) -
Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
by: Kinga Kołcz, et al.
Published: (2023) -
Which is the ideal JAK inhibitor for alopecia areata - Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
by: Kabir Sardana, et al.
Published: (2023) -
The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
by: Diqin Yan, et al.
Published: (2022) -
Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
by: Ting Yan, et al.
Published: (2024)